Anti-Human Tissue Factor Pathway Inhibitor (C-Terminal) Antibody
Goat Anti-Human Polyclonal Antibody
|Calculated MW||35015 Da|
|Purification||Antisera to TFPI were raised by repeated immunisations of goats with highly purified antigen. Purified IgG was prepared from whole serum by affinity chromatography.|
|Immunogen||Peptide sequence VKIAYEEIFVKNM corresponding to the C-terminus of TFPI (NP_006278).|
|Shelf Life||18 months from date of despatch.|
|Other Names||Tissue factor pathway inhibitor, TFPI, Extrinsic pathway inhibitor, EPI, Lipoprotein-associated coagulation inhibitor, LACI, TFPI, LACI, TFPI1|
|Target/Specificity||ABD11405 recognises tissue factor pathway inhibitor (TFPI), also known as Lipoprotein-associated coagulation inhibitor (LACI). TFPI is a protease inhibitor that helps to maintain haemostasis by inhibiting factor Xa and the Factor VIIa/Tissue factor (TF) complex. TFPI is also reported to associate with lipoproteins in plasma.|
|Preservative & Stabilisers||0.02% Sodium Azide; 0.5% Bovine Serum Albumin;|
|Storage||Store at +4℃ or at -20 ℃.|
|Precautions||Anti-Human Tissue Factor Pathway Inhibitor (C-Terminal) Antibody is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1. Wun, T. C. et al. (1988) Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.J. Biol. Chem. 263: 6001 - 6004.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.